Sunday, January 29, 2023

Tag: Big Pharma

Malcharist: Fact or Fiction? Big Pharma, Psychiatry’s Key Opinion Leaders and...

15
Malcharist, by Paul John Scott, is a fictional account of one of psychiatry’s most influential key opinion leaders (KOLs), his ghostwriter, and a journalist on the trail of a big scandal in the world of Big Pharma.

Are Regulatory Bodies Prioritising Drug Company Interests Over Public Safety?

31
The UK’s Medicines & Healthcare Products Regulatory Agency is refusing to respond to the concerns of psychiatrists, parliamentarians, patients and other experts about the impending licensing of the street drug ketamine as a treatment for depression.

Getting Pharma Out of Medical Education: An Interview with Dr. Adriane...

5
MIA's Gavin Crowell-Williamson interviews PharmedOut founder Dr. Adriane Fugh-Berman about Big Pharma's influence on medical education.

Conflicts of Interest Questioned in Review of Prescribed Drug Dependence

8
An interview with Professor Sami Timimi, Psychiatrist Peter Gordon and campaigner Stevie Lewis, who talk about the potential for conflicts of interest with the UK Royal College of Psychiatrists participation in a Government-led review of Prescribed Drug Dependence.

E-book: “Ghost-Managed Medicine: Big Pharma’s Invisible Hands”

0
Sergio Sismondo's new book from Mattering Press explores how Big Pharma controls drug research and marketing at every stage, maximizing industry profits at the expense...

Patients’ Drug Options Under Medicaid Influenced by Drugmakers

0
From NPR: "A Center for Public Integrity and NPR investigation found drug companies have infiltrated nearly every part of the process that determines how their drugs will be covered...

The Women’s Libido Pill is Back, and So is the Controversy

1
From Bloomberg: "The counterattack against the drug has been furious, and in many instances led by women. These forces contend that one woman’s sexual abnormal...

How Drug Companies Sell Treatments By Inventing Diseases

2
From Yahoo! News: "There’s a substantial body of medical literature dating back to the early ’90s about the practice known as 'disease mongering.' Pharmaceutical companies...

FDA Repays Industry by Rushing Risky Drugs to Market

0
From ProPublica: "The FDA is increasingly green-lighting expensive drugs despite dangerous or little-known side effects and inconclusive evidence that they curb or cure disease. Once...

Scientific Opinions — For Sale

2
From Medium: "This is where evidence based medicine is supposed to shine, by demanding randomized trials to prove that certain procedures/drugs either work or don’t....

Massive Reforms for Pharmaceutical System Proposed

18
The US/Canadian Pharmaceutical Policy Reform Working Group proposes universal drug coverage and ambitious reforms to the pharmaceutical system.

Doctors Launch Sweeping Pharmaceutical Reform Proposal

0
From Medical Xpress: A group of 21 prominent physicians have released a comprehensive proposal to guarantee everyone access to safe, innovative, and affordable medication. The proposed reforms...

Drugmaker Group Sets Lobbying Record

2
From Bloomberg: The Pharmaceutical Research and Manufacturers of America (PhRMA) spent $9.96 million on federal lobbying in the first three months of 2018, representing an...

Big Pharma: The Global Effect

3
In this piece for Vision Magazine, Danit Felber details the U.S. pharmaceutical industry's efforts to stomp out foreign competition. "What does this mean practically? A nonprofit...

Patient Advocacy Groups Take In Millions From Drugmakers

0
Kaiser Health News has launched a new database called Pre$scription for Power, which exposes donations pharmaceutical companies have made to patient advocacy groups. The...

The Corruption of Evidence Based Medicine — Killing for Profit

0
From Medium: According to many prominent physicians, so-called "evidence based medicine" is no longer useful. Much of the evidence base has been corrupted by the...

The Pharmaceutical Industry in Contemporary Capitalism

0
In this piece for the Monthly Review, Joel Lexchin details four strategies that the pharmaceutical industry is utilizing in order to maintain its high level...

The More Opioids Doctors Prescribe, the More Money They Make

2
An exclusive analysis by CNN and researchers at Harvard University found that opioid manufacturers are paying physicians huge sums of money — and that doctors with higher...

Bill to Force Pharma to Disclose Payments to Advocacy Groups

0
From STAT: Last month, Senator Claire McCaskill released a report showing that opioid manufacturers had funneled nearly $9 million to patient advocacy groups between 2012...

Pharma Backing of Advocacy Groups: A Call for Transparency

3
From HealthNewsReview.org: In light of the opioid crisis, lawmakers are growing increasingly concerned about financial conflicts of interest in patient advocacy groups. Ontario has enacted...

Pharma-Funded Charities v. Health and Human Services

0
From The Health Law & Policy Brief: Last month, Patient Services Inc. (PSI), a pharmaceutical industry-funded charity, launched a lawsuit against the Department of Health...

Pharma, Under Attack for Drug Prices, Started an Industry War

0
From The Washington Post: In 2017, numerous politicians, advocacy groups, and other stakeholders began to raise questions about the rising costs of prescription drugs. Under attack,...

PhRMA Ups Lobbying by 30 Percent This Year

0
From The Hill: The pharmaceutical industry's top trade group, the Pharmaceutical Research and Manufacturers of America (PhRMA), has increased its federal lobbying expenditures by 30...

How Big Pharma Infiltrated the Boston Museum of Science

2
From CounterPunch: Last spring, an exhibit promoting mainstream mental health ideologies debuted at the Boston Museum of Science. The exhibit was funded by NAMI and...

Researchers Expose Pharmaceutical Industry Misconduct and Corruption

8
Corruption of pharmaceutical industry sponsored clinical trials identified as a “major obstacle” facing evidence-based medicine.